Dimensional Fund Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.01M | Buy |
1,051,996
+312,945
| +42% | +$1.42M | ﹤0.01% | 2489 |
|
|
2026
Q1 | $3.33M | Sell |
739,051
-548,396
| -43% | -$2.86M | ﹤0.01% | 2607 |
|
|
2025
Q4 | $7.92M | Sell |
1,287,447
-408,449
| -24% | -$2.96M | ﹤0.01% | 2367 |
|
|
2025
Q3 | $12.3M | Sell |
1,695,896
-377,322
| -18% | -$2.24M | ﹤0.01% | 2229 |
|
|
2025
Q2 | $11M | Sell |
2,073,218
-139,992
| -6% | -$827K | ﹤0.01% | 2242 |
|
|
2025
Q1 | $19.6M | Sell |
2,213,210
-59,145
| -3% | -$710K | ﹤0.01% | 1955 |
|
|
2024
Q4 | $31.2M | Sell |
2,272,355
-151,122
| -6% | -$2.79M | 0.01% | 1796 |
|
|
2024
Q3 | $66.4M | Sell |
2,423,477
-353,482
| -13% | -$9.57M | 0.02% | 1337 |
|
|
2024
Q2 | $67.9M | Buy |
2,776,959
+75,445
| +3% | +$1.66M | 0.02% | 1244 |
|
|
2024
Q1 | $57.6M | Buy |
2,701,514
+20,596
| +0.8% | +$443K | 0.02% | 1367 |
|
|
2023
Q4 | $51.3M | Buy |
2,680,918
+89,330
| +3% | +$1.55M | 0.02% | 1429 |
|
|
2023
Q3 | $41.6M | Sell |
2,591,588
-81,883
| -3% | -$1.56M | 0.01% | 1472 |
|
|
2023
Q2 | $62M | Sell |
2,673,471
-50,925
| -2% | -$1.11M | 0.02% | 1207 |
|
|
2023
Q1 | $63.3M | Buy |
+2,724,396
| New | +$55.3M | 0.02% | 1145 |
|
|
2022
Q3 | $46.4M | Sell |
2,432,450
-108,757
| -4% | -$2.5M | 0.02% | 1286 |
|
|
2022
Q2 | $46.2M | Sell |
2,541,207
-19,737
| -0.8% | -$410K | 0.02% | 1346 |
|
|
2022
Q1 | $64.5M | Sell |
2,560,944
-74,859
| -3% | -$1.92M | 0.02% | 1188 |
|
|
2021
Q4 | $72.7M | Sell |
2,635,803
-50,573
| -2% | -$1.47M | 0.02% | 1132 |
|
|
2021
Q3 | $86.7M | Sell |
2,686,376
-82,328
| -3% | -$2.73M | 0.03% | 956 |
|
|
2021
Q2 | $84.7M | Buy |
2,768,704
+37,825
| +1% | +$1.09M | 0.03% | 996 |
|
|
2021
Q1 | $82.9M | Sell |
2,730,879
-31,158
| -1% | -$884K | 0.03% | 993 |
|
|
2020
Q4 | $54.6M | Sell |
2,762,037
-7,910
| -0.3% | -$128K | 0.02% | 1294 |
|
|
2020
Q3 | $36.1M | Sell |
2,769,947
-68,230
| -2% | -$863K | 0.02% | 1459 |
|
|
2020
Q2 | $32.2M | Sell |
2,838,177
-147,563
| -5% | -$2.1M | 0.01% | 1562 |
|
|
2020
Q1 | $42.7M | Buy |
2,985,740
+14,851
| +0.5% | +$314K | 0.02% | 1158 |
|
|
2019
Q4 | $80.9M | Buy |
2,970,889
+19,496
| +0.7% | +$536K | 0.03% | 916 |
|
|
2019
Q3 | $84.5M | Buy |
2,951,393
+225,317
| +8% | +$6.57M | 0.03% | 831 |
|
|
2019
Q2 | $75.7M | Buy |
2,726,076
+105,172
| +4% | +$2.97M | 0.03% | 967 |
|
|
2019
Q1 | $87M | Buy |
2,620,904
+87,501
| +3% | +$2.66M | 0.03% | 795 |
|
|
2018
Q4 | $73.6M | Sell |
2,533,403
-108,878
| -4% | -$3.92M | 0.03% | 830 |
|
|
2018
Q3 | $122M | Sell |
2,642,281
-412,982
| -14% | -$18.4M | 0.05% | 540 |
|
|
2018
Q2 | $114M | Sell |
3,055,263
-461,077
| -13% | -$15.6M | 0.05% | 552 |
|
|
2018
Q1 | $104M | Sell |
3,516,340
-15,544
| -0.4% | -$526K | 0.04% | 598 |
|
|
2017
Q4 | $121M | Sell |
3,531,884
-48,197
| -1% | -$1.63M | 0.05% | 489 |
|
|
2017
Q3 | $130M | Buy |
3,580,081
+149,865
| +4% | +$4.27M | 0.06% | 417 |
|
|
2017
Q2 | $88.6M | Buy |
3,430,216
+787,396
| +30% | +$16.7M | 0.04% | 613 |
|
|
2017
Q1 | $50.7M | Buy |
2,642,820
+987,966
| +60% | +$17.5M | 0.02% | 1167 |
|
|
2016
Q4 | $27.6M | Buy |
1,654,854
+204,049
| +14% | +$3.69M | 0.01% | 1726 |
|
|
2016
Q3 | $29.9M | Buy |
1,450,805
+2,300
| +0.2% | +$58.3K | 0.02% | 1576 |
|
|
2016
Q2 | $44.3M | Buy |
1,448,505
+24,137
| +2% | +$839K | 0.03% | 1098 |
|
|
2016
Q1 | $53.3M | Buy |
1,424,368
+83,327
| +6% | +$3.14M | 0.03% | 851 |
|
|
2015
Q4 | $57.9M | Buy |
1,341,041
+125,196
| +10% | +$5.29M | 0.04% | 722 |
|
|
2015
Q3 | $45.6M | Buy |
1,215,845
+80,662
| +7% | +$2.86M | 0.03% | 892 |
|
|
2015
Q2 | $38.6M | Sell |
1,135,183
-1,450
| -0.1% | -$49.3K | 0.02% | 1147 |
|
|
2015
Q1 | $40.2M | Buy |
1,136,633
+1,974
| +0.2% | +$70.7K | 0.03% | 1060 |
|
|
2014
Q4 | $38.6M | Buy |
1,134,659
+18,522
| +2% | +$657K | 0.03% | 1035 |
|
|
2014
Q3 | $43M | Buy |
1,116,137
+7,292
| +0.7% | +$272K | 0.03% | 820 |
|
|
2014
Q2 | $43.2M | Buy |
1,108,845
+19,897
| +2% | +$740K | 0.03% | 847 |
|
|
2014
Q1 | $37.2M | Sell |
1,088,948
-20,310
| -2% | -$629K | 0.03% | 905 |
|
|
2013
Q4 | $23.3M | Sell |
1,109,258
-10,672
| -1% | -$270K | 0.02% | 1374 |
|
|
2013
Q3 | $26.3M | Buy |
1,119,930
+244,306
| +28% | +$6.94M | 0.02% | 1092 |
|
|
2013
Q2 | $23.5M | Buy |
+875,624
| New | +$25.4M | 0.02% | 1089 |
|
Other funds holding MYGN
VPC
Dimensional Fund Advisors's MYGN Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Myriad Genetics (MYGN) stake by 42% in Q2 2026, buying an estimated $1.42M and bringing the position to 1,051,996 shares worth $6.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2489.
Dimensional Fund Advisors first reported a position in MYGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $130M in Q3 2017. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Dimensional Fund Advisors held 1,051,996 shares of Myriad Genetics worth $6.01M as of Q2 2026.
- Dimensional Fund Advisors bought 312,945 Myriad Genetics shares in Q2 2026, an estimated $1.42M.
- Myriad Genetics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2489 holding.
- Dimensional Fund Advisors first reported a position in Myriad Genetics in Q2 2013 and has held it in 52 quarters since.
- Dimensional Fund Advisors's Myriad Genetics position peaked at $130M in Q3 2017.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.